lucarista / shutterstock.com
Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly £1.7m ($2.3m) in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Roche, Insulet, patent, injunction, claim, insulin, solicitors, tubeless, pump